dr. bruix discusses the updated findings of the resorce trial in hcc
Published 7 years ago • 86 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
2:31
dr. bruix on the phase iii resorce trial in hcc
-
2:02
dr. bruix discusses the application of regorafenib in hcc
-
2:04
dr. bruix on regorafenib in second-line hcc
-
5:22
impact of resorce findings on hcc clinical practice
-
0:58
the significance of the resorce trial in hcc
-
1:28
dr. jordi bruix on efficacy and safety of regorafenib in hcc after sorafenib
-
1:47
dr. jordi bruix on the impact regorafenib will have on liver cancer treatment
-
2:41
the beginning of the end for lung cancer. new vaccine trial explained.
-
2:28
dr. abou-alfa discusses results of the celestial trial in advanced hcc
-
5:10
understanding the resorce data in second-line hcc
-
7:35
diagnosing hcc: when a biopsy is needed
-
1:22
dr. cheng on phase iii findings of lenvatinib in hcc
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
0:58
dr. abou-alfa on significance of resorce trial for hcc
-
8:29
incorporating regorafenib in the hcc treatment landscape
-
0:49
dr. daniele on impact of regorafenib in hcc
-
5:40
sorafenib initiation after tace in hcc
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
3:00
ongoing clinical trials in second-line hcc